CA3064612A1 - A htp genomic engineering platform for improving escherichia coli - Google Patents

Info

Publication number

CA3064612A1

CA3064612A1 CA3064612A CA3064612A CA3064612A1 CA 3064612 A1 CA3064612 A1 CA 3064612A1 CA 3064612 A CA3064612 A CA 3064612A CA 3064612 A CA3064612 A CA 3064612A CA 3064612 A1 CA3064612 A1 CA 3064612A1

Authority

CA

Canada

Prior art keywords

coli strain

library

gene

coli

swap

Prior art date

2017-06-06

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 241000588724 Escherichia coli Species 0.000 title claims abstract description 657
• 230000002068 genetic effect Effects 0.000 claims abstract description 249
• 238000013461 design Methods 0.000 claims abstract description 165
• 108090000623 proteins and genes Proteins 0.000 claims description 563
• 238000000034 method Methods 0.000 claims description 375
• 102000004169 proteins and genes Human genes 0.000 claims description 222
• 210000004027 cell Anatomy 0.000 claims description 197
• 230000007614 genetic variation Effects 0.000 claims description 153
• 230000014509 gene expression Effects 0.000 claims description 139
• 230000000813 microbial effect Effects 0.000 claims description 128
• 238000004519 manufacturing process Methods 0.000 claims description 125
• 230000006872 improvement Effects 0.000 claims description 122
• 230000015556 catabolic process Effects 0.000 claims description 116
• 238000006731 degradation reaction Methods 0.000 claims description 116
• 230000004568 DNA-binding Effects 0.000 claims description 113
• 102000004190 Enzymes Human genes 0.000 claims description 109
• 108090000790 Enzymes Proteins 0.000 claims description 109
• 229940088598 enzyme Drugs 0.000 claims description 102
• 108020004414 DNA Proteins 0.000 claims description 99
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 83
• 239000002773 nucleotide Substances 0.000 claims description 72
• 125000003729 nucleotide group Chemical group 0.000 claims description 72
• 150000007523 nucleic acids Chemical group 0.000 claims description 63
• 230000017854 proteolysis Effects 0.000 claims description 62
• 230000001851 biosynthetic effect Effects 0.000 claims description 60
• 230000001976 improved effect Effects 0.000 claims description 60
• 230000027455 binding Effects 0.000 claims description 59
• 230000037361 pathway Effects 0.000 claims description 53
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 44
• 238000012216 screening Methods 0.000 claims description 41
• 108020004705 Codon Proteins 0.000 claims description 40
• 150000001413 amino acids Chemical class 0.000 claims description 37
• 230000001105 regulatory effect Effects 0.000 claims description 36
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 33
• 241000701959 Escherichia virus Lambda Species 0.000 claims description 29
• 230000001965 increasing effect Effects 0.000 claims description 28
• 230000037431 insertion Effects 0.000 claims description 28
• 238000003780 insertion Methods 0.000 claims description 28
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
• 230000037430 deletion Effects 0.000 claims description 26
• 238000012217 deletion Methods 0.000 claims description 26
• 230000001747 exhibiting effect Effects 0.000 claims description 25
• 102000039446 nucleic acids Human genes 0.000 claims description 25
• 108020004707 nucleic acids Proteins 0.000 claims description 25
• 229920001184 polypeptide Polymers 0.000 claims description 25
• 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 23
• 102000040430 polynucleotide Human genes 0.000 claims description 23
• 108091033319 polynucleotide Proteins 0.000 claims description 23
• 239000002157 polynucleotide Substances 0.000 claims description 23
• BFAKENXZKHGIGE-UHFFFAOYSA-N bis(2,3,5,6-tetrafluoro-4-iodophenyl)diazene Chemical compound FC1=C(C(=C(C(=C1F)I)F)F)N=NC1=C(C(=C(C(=C1F)F)I)F)F BFAKENXZKHGIGE-UHFFFAOYSA-N 0.000 claims description 21
• 108091081024 Start codon Proteins 0.000 claims description 20
• -1 beromun (tasonermin) Proteins 0.000 claims description 20
• 150000001875 compounds Chemical class 0.000 claims description 20
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 18
• 210000003705 ribosome Anatomy 0.000 claims description 18
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 16
• 238000002708 random mutagenesis Methods 0.000 claims description 16
• 150000003384 small molecules Chemical class 0.000 claims description 16
• 229910052725 zinc Inorganic materials 0.000 claims description 16
• 239000011701 zinc Substances 0.000 claims description 16
• 239000002207 metabolite Substances 0.000 claims description 15
• FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 14
• 108020003589 5' Untranslated Regions Proteins 0.000 claims description 13
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 13
• 102000054765 polymorphisms of proteins Human genes 0.000 claims description 13
• 108010029961 Filgrastim Proteins 0.000 claims description 12
• 239000004472 Lysine Substances 0.000 claims description 12
• 229960000074 biopharmaceutical Drugs 0.000 claims description 12
• 239000000446 fuel Substances 0.000 claims description 11
• 238000002744 homologous recombination Methods 0.000 claims description 11
• 230000006801 homologous recombination Effects 0.000 claims description 11
• 230000003834 intracellular effect Effects 0.000 claims description 10
• 101150078419 zwf gene Proteins 0.000 claims description 10
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims description 9
• 102000004877 Insulin Human genes 0.000 claims description 9
• 108090001061 Insulin Proteins 0.000 claims description 9
• UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 9
• JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 9
• 229940125396 insulin Drugs 0.000 claims description 9
• 229960004999 lycopene Drugs 0.000 claims description 9
• 235000012661 lycopene Nutrition 0.000 claims description 9
• OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 9
• 239000001751 lycopene Substances 0.000 claims description 9
• 150000007524 organic acids Chemical class 0.000 claims description 9
• 230000003094 perturbing effect Effects 0.000 claims description 9
• ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 9
• 101800000407 Brain natriuretic peptide 32 Proteins 0.000 claims description 8
• 108010000521 Human Growth Hormone Proteins 0.000 claims description 8
• 102000002265 Human Growth Hormone Human genes 0.000 claims description 8
• 239000000854 Human Growth Hormone Substances 0.000 claims description 8
• COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 claims description 8
• 108010050904 Interferons Proteins 0.000 claims description 8
• 102000014150 Interferons Human genes 0.000 claims description 8
• 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 claims description 8
• 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 claims description 8
• BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims description 8
• 108010017271 denileukin diftitox Proteins 0.000 claims description 8
• 101150118992 dxr gene Proteins 0.000 claims description 8
• 229960004177 filgrastim Drugs 0.000 claims description 8
• 108010049491 glucarpidase Proteins 0.000 claims description 8
• 229940079322 interferon Drugs 0.000 claims description 8
• 108010010648 interferon alfacon-1 Proteins 0.000 claims description 8
• 108700037519 pegvisomant Proteins 0.000 claims description 8
• 108010051412 reteplase Proteins 0.000 claims description 8
• 210000004899 c-terminal region Anatomy 0.000 claims description 7
• 101150033534 lysA gene Proteins 0.000 claims description 6
• 101150099894 GDHA gene Proteins 0.000 claims description 5
• 101150047711 acs gene Proteins 0.000 claims description 5
• 101150056470 dxs gene Proteins 0.000 claims description 5
• 101150075592 idi gene Proteins 0.000 claims description 5
• 238000009776 industrial production Methods 0.000 claims description 5
• HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 claims description 4
• HPNRHPKXQZSDFX-UHFFFAOYSA-N 2-[[2-[[2-[[2-[[2-[[6-amino-2-[[52-[[2-[[2-[[2-[[5-amino-2-[[2-[[2-[[6-amino-2-[[1-(2-amino-3-hydroxypropanoyl)pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-butan-2-yl-31,43-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid Chemical compound N1C(=O)C(NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C2N(CCC2)C(=O)C(N)CO)C(C)C)CSSCC(C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC=2N=CNC=2)C(O)=O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(O)=O)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C1CC1=CC=CC=C1 HPNRHPKXQZSDFX-UHFFFAOYSA-N 0.000 claims description 4
• 102000055006 Calcitonin Human genes 0.000 claims description 4
• 108060001064 Calcitonin Proteins 0.000 claims description 4
• 101100056285 Escherichia coli (strain K12) ariR gene Proteins 0.000 claims description 4
• 101100126274 Escherichia coli (strain K12) iraM gene Proteins 0.000 claims description 4
• 102000051325 Glucagon Human genes 0.000 claims description 4
• 108060003199 Glucagon Proteins 0.000 claims description 4
• 102000018997 Growth Hormone Human genes 0.000 claims description 4
• 108010051696 Growth Hormone Proteins 0.000 claims description 4
• 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 claims description 4
• 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 claims description 4
• 102000013266 Human Regular Insulin Human genes 0.000 claims description 4
• 108010090613 Human Regular Insulin Proteins 0.000 claims description 4
• 108010057186 Insulin Glargine Proteins 0.000 claims description 4
• 108010065920 Insulin Lispro Proteins 0.000 claims description 4
• 108010092217 Long-Acting Insulin Proteins 0.000 claims description 4
• 102000016261 Long-Acting Insulin Human genes 0.000 claims description 4
• 229940100066 Long-acting insulin Drugs 0.000 claims description 4
• 102000003982 Parathyroid hormone Human genes 0.000 claims description 4
• 108090000445 Parathyroid hormone Proteins 0.000 claims description 4
• 108010092464 Urate Oxidase Proteins 0.000 claims description 4
• 229960004238 anakinra Drugs 0.000 claims description 4
• 101150013067 appY gene Proteins 0.000 claims description 4
• 101150050866 argD gene Proteins 0.000 claims description 4
• 101150107204 asd gene Proteins 0.000 claims description 4
• 101150034124 ask gene Proteins 0.000 claims description 4
• 229960004015 calcitonin Drugs 0.000 claims description 4
• 229960003773 calcitonin (salmon synthetic) Drugs 0.000 claims description 4
• 101150081158 crtB gene Proteins 0.000 claims description 4
• 101150000046 crtE gene Proteins 0.000 claims description 4
• 101150085103 crtY gene Proteins 0.000 claims description 4
• 101150011371 dapA gene Proteins 0.000 claims description 4
• 101150073654 dapB gene Proteins 0.000 claims description 4
• 101150064923 dapD gene Proteins 0.000 claims description 4
• 101150000582 dapE gene Proteins 0.000 claims description 4
• 101150062988 dapF gene Proteins 0.000 claims description 4
• 101150057904 ddh gene Proteins 0.000 claims description 4
• 229960002923 denileukin diftitox Drugs 0.000 claims description 4
• 101150089768 elbB gene Proteins 0.000 claims description 4
• 101150057497 fbp gene Proteins 0.000 claims description 4
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims description 4
• 229960004666 glucagon Drugs 0.000 claims description 4
• 229960004859 glucarpidase Drugs 0.000 claims description 4
• 239000000122 growth hormone Substances 0.000 claims description 4
• 101150063051 hom gene Proteins 0.000 claims description 4
• WNRQPCUGRUFHED-DETKDSODSA-N humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 claims description 4
• 102000058004 human PTH Human genes 0.000 claims description 4
• 229940065770 humatrope Drugs 0.000 claims description 4
• 229940103471 humulin Drugs 0.000 claims description 4
• 101150118781 icd gene Proteins 0.000 claims description 4
• 229940090438 infergen Drugs 0.000 claims description 4
• PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims description 4
• 229960002068 insulin lispro Drugs 0.000 claims description 4
• 229960003358 interferon alfacon-1 Drugs 0.000 claims description 4
• 101150064873 ispA gene Proteins 0.000 claims description 4
• 101150000769 ispB gene Proteins 0.000 claims description 4
• 101150014059 ispD gene Proteins 0.000 claims description 4
• 101150068863 ispE gene Proteins 0.000 claims description 4
• 101150018742 ispF gene Proteins 0.000 claims description 4
• 101150081094 ispG gene Proteins 0.000 claims description 4
• 101150017044 ispH gene Proteins 0.000 claims description 4
• 229940054136 kineret Drugs 0.000 claims description 4
• 229940060975 lantus Drugs 0.000 claims description 4
• 229940076783 lucentis Drugs 0.000 claims description 4
• 101150044424 lysE gene Proteins 0.000 claims description 4
• 229940054205 natrecor Drugs 0.000 claims description 4
• 229960001267 nesiritide Drugs 0.000 claims description 4
• HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 claims description 4
• 229940029345 neupogen Drugs 0.000 claims description 4
• 229940100027 ontak Drugs 0.000 claims description 4
• 239000000199 parathyroid hormone Substances 0.000 claims description 4
• 229960001319 parathyroid hormone Drugs 0.000 claims description 4
• 101150088738 pckA gene Proteins 0.000 claims description 4
• 229960002995 pegvisomant Drugs 0.000 claims description 4
• 101150053253 pgi gene Proteins 0.000 claims description 4
• 101150023641 ppc gene Proteins 0.000 claims description 4
• 101150096049 pyc gene Proteins 0.000 claims description 4
• 229960003876 ranibizumab Drugs 0.000 claims description 4
• 229960002917 reteplase Drugs 0.000 claims description 4
• 108010068072 salmon calcitonin Proteins 0.000 claims description 4
• 229960004532 somatropin Drugs 0.000 claims description 4
• 229940099077 somavert Drugs 0.000 claims description 4
• 229960003102 tasonermin Drugs 0.000 claims description 4
• 229940005267 urate oxidase Drugs 0.000 claims description 4
• 229940110059 voraxaze Drugs 0.000 claims description 4
• 101150106048 ymgA gene Proteins 0.000 claims description 4
• 101150011633 crtI gene Proteins 0.000 claims description 3
• 229960003161 interferon beta-1b Drugs 0.000 claims description 3
• 201000007795 Bietti crystalline corneoretinal dystrophy Diseases 0.000 claims 2
• 208000008319 Bietti crystalline dystrophy Diseases 0.000 claims 2
• 102100040018 Interferon alpha-2 Human genes 0.000 claims 2
• 108010079944 Interferon-alpha2b Proteins 0.000 claims 2
• 108010005714 Interferon beta-1b Proteins 0.000 claims 1
• 238000006911 enzymatic reaction Methods 0.000 claims 1
• 238000010801 machine learning Methods 0.000 abstract description 8
• 238000003909 pattern recognition Methods 0.000 abstract description 5
• 230000035772 mutation Effects 0.000 description 177
• 235000018102 proteins Nutrition 0.000 description 158
• 239000000047 product Substances 0.000 description 76
• 239000002585 base Substances 0.000 description 66
• 125000003275 alpha amino acid group Chemical group 0.000 description 57
• 230000009286 beneficial effect Effects 0.000 description 56
• 230000008569 process Effects 0.000 description 54
• 238000013459 approach Methods 0.000 description 53
• 230000000694 effects Effects 0.000 description 53
• 239000013598 vector Substances 0.000 description 42
• 230000000875 corresponding effect Effects 0.000 description 40
• 238000004458 analytical method Methods 0.000 description 37
• 239000013612 plasmid Substances 0.000 description 36
• 230000006870 function Effects 0.000 description 34
• 230000004044 response Effects 0.000 description 34
• 229940024606 amino acid Drugs 0.000 description 33
• 235000001014 amino acid Nutrition 0.000 description 33
• 238000013518 transcription Methods 0.000 description 32
• 230000035897 transcription Effects 0.000 description 30
• 230000002103 transcriptional effect Effects 0.000 description 30
• 241000894006 Bacteria Species 0.000 description 29
• 239000011159 matrix material Substances 0.000 description 25
• 238000000855 fermentation Methods 0.000 description 23
• 230000004151 fermentation Effects 0.000 description 23
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 22
• 230000008236 biological pathway Effects 0.000 description 22
• 230000002922 epistatic effect Effects 0.000 description 21
• 230000003993 interaction Effects 0.000 description 21
• 230000000670 limiting effect Effects 0.000 description 21
• 244000005700 microbiome Species 0.000 description 21
• 239000013615 primer Substances 0.000 description 21
• 108700026244 Open Reading Frames Proteins 0.000 description 20
• 238000007596 consolidation process Methods 0.000 description 20
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 18
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 18
• 238000013507 mapping Methods 0.000 description 18
• 239000000758 substrate Substances 0.000 description 18
• 230000004927 fusion Effects 0.000 description 17
• 230000003505 mutagenic effect Effects 0.000 description 17
• 230000006798 recombination Effects 0.000 description 17
• 238000005215 recombination Methods 0.000 description 17
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 16
• 108020004999 messenger RNA Proteins 0.000 description 16
• 230000014616 translation Effects 0.000 description 16
• 238000012239 gene modification Methods 0.000 description 15
• 238000010353 genetic engineering Methods 0.000 description 15
• 231100000219 mutagenic Toxicity 0.000 description 15
• 238000005457 optimization Methods 0.000 description 15
• 230000007115 recruitment Effects 0.000 description 14
• 238000013519 translation Methods 0.000 description 14
• 241000196324 Embryophyta Species 0.000 description 13
• 230000002457 bidirectional effect Effects 0.000 description 13
• 230000001627 detrimental effect Effects 0.000 description 13
• 235000019441 ethanol Nutrition 0.000 description 13
• 230000005017 genetic modification Effects 0.000 description 13
• 235000013617 genetically modified food Nutrition 0.000 description 13
• 238000012360 testing method Methods 0.000 description 13
• 238000007792 addition Methods 0.000 description 12
• 239000012634 fragment Substances 0.000 description 12
• 230000007246 mechanism Effects 0.000 description 12
• 238000002703 mutagenesis Methods 0.000 description 12
• 231100000350 mutagenesis Toxicity 0.000 description 12
• 230000009466 transformation Effects 0.000 description 12
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
• 108091026890 Coding region Proteins 0.000 description 11
• 241000206602 Eukaryota Species 0.000 description 11
• 102000000470 PDZ domains Human genes 0.000 description 11
• 108050008994 PDZ domains Proteins 0.000 description 11
• 238000004422 calculation algorithm Methods 0.000 description 11
• 229910052799 carbon Inorganic materials 0.000 description 11
• 230000001413 cellular effect Effects 0.000 description 11
• 230000008859 change Effects 0.000 description 11
• 230000004077 genetic alteration Effects 0.000 description 11
• 231100000118 genetic alteration Toxicity 0.000 description 11
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 10
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 10
• 108091032917 Transfer-messenger RNA Proteins 0.000 description 10
• 230000015572 biosynthetic process Effects 0.000 description 10
• 238000004113 cell culture Methods 0.000 description 10
• 238000006243 chemical reaction Methods 0.000 description 10
• 238000002474 experimental method Methods 0.000 description 10
• 238000010362 genome editing Methods 0.000 description 10
• 230000002441 reversible effect Effects 0.000 description 10
• 241000203069 Archaea Species 0.000 description 9
• 108091034117 Oligonucleotide Proteins 0.000 description 9
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 9
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 9
• 238000005516 engineering process Methods 0.000 description 9
• 125000000524 functional group Chemical group 0.000 description 9
• 102000037865 fusion proteins Human genes 0.000 description 9
• 108020001507 fusion proteins Proteins 0.000 description 9
• 238000013537 high throughput screening Methods 0.000 description 9
• 230000004048 modification Effects 0.000 description 9
• 238000012986 modification Methods 0.000 description 9
• 239000000126 substance Substances 0.000 description 9
• 230000008901 benefit Effects 0.000 description 8
• 230000001939 inductive effect Effects 0.000 description 8
• 239000000203 mixture Substances 0.000 description 8
• 238000012545 processing Methods 0.000 description 8
• 230000002829 reductive effect Effects 0.000 description 8
• 241000894007 species Species 0.000 description 8
• 230000014621 translational initiation Effects 0.000 description 8
• 241000186216 Corynebacterium Species 0.000 description 7
• 241000238631 Hexapoda Species 0.000 description 7
• 238000012512 characterization method Methods 0.000 description 7
• 238000010367 cloning Methods 0.000 description 7
• 238000009795 derivation Methods 0.000 description 7
• 230000012010 growth Effects 0.000 description 7
• 230000000977 initiatory effect Effects 0.000 description 7
• 230000010354 integration Effects 0.000 description 7
• 239000003446 ligand Substances 0.000 description 7
• 230000002503 metabolic effect Effects 0.000 description 7
• 230000007935 neutral effect Effects 0.000 description 7
• 238000003908 quality control method Methods 0.000 description 7
• 238000003786 synthesis reaction Methods 0.000 description 7
• 241000186226 Corynebacterium glutamicum Species 0.000 description 6
• 101100174653 Dictyostelium discoideum g6pd-2 gene Proteins 0.000 description 6
• 241000282414 Homo sapiens Species 0.000 description 6
• 102000009572 RNA Polymerase II Human genes 0.000 description 6
• 108010009460 RNA Polymerase II Proteins 0.000 description 6
• 101150085516 ZWF1 gene Proteins 0.000 description 6
• 239000002253 acid Substances 0.000 description 6
• 230000004075 alteration Effects 0.000 description 6
• 230000003321 amplification Effects 0.000 description 6
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• 238000012258 culturing Methods 0.000 description 6
• 230000007423 decrease Effects 0.000 description 6
• 238000003199 nucleic acid amplification method Methods 0.000 description 6
• 230000005855 radiation Effects 0.000 description 6
• 101150026856 zwf2 gene Proteins 0.000 description 6
• 108091035707 Consensus sequence Proteins 0.000 description 5
• 230000007748 combinatorial effect Effects 0.000 description 5
• 239000013256 coordination polymer Substances 0.000 description 5
• 230000001419 dependent effect Effects 0.000 description 5
• 230000003116 impacting effect Effects 0.000 description 5
• 230000002452 interceptive effect Effects 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 239000003471 mutagenic agent Substances 0.000 description 5
• 230000008929 regeneration Effects 0.000 description 5
• 238000011069 regeneration method Methods 0.000 description 5
• 238000012163 sequencing technique Methods 0.000 description 5
• 239000000243 solution Substances 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• 238000011144 upstream manufacturing Methods 0.000 description 5
• 108700028369 Alleles Proteins 0.000 description 4
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• 239000002028 Biomass Substances 0.000 description 4
• 241000195493 Cryptophyta Species 0.000 description 4
• 238000007702 DNA assembly Methods 0.000 description 4
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
• PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 4
• 241000233866 Fungi Species 0.000 description 4
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 4
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
• 229930006000 Sucrose Natural products 0.000 description 4
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
• 241000700605 Viruses Species 0.000 description 4
• 150000007513 acids Chemical class 0.000 description 4
• 230000000996 additive effect Effects 0.000 description 4
• 239000003242 anti bacterial agent Substances 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 230000010261 cell growth Effects 0.000 description 4
• 239000003795 chemical substances by application Substances 0.000 description 4
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 4
• 210000000349 chromosome Anatomy 0.000 description 4
• 230000008045 co-localization Effects 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 238000010586 diagram Methods 0.000 description 4
• 238000009826 distribution Methods 0.000 description 4
• 230000037442 genomic alteration Effects 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
• 230000037353 metabolic pathway Effects 0.000 description 4
• 231100000707 mutagenic chemical Toxicity 0.000 description 4
• 230000002018 overexpression Effects 0.000 description 4
• 239000012071 phase Substances 0.000 description 4
• 230000001323 posttranslational effect Effects 0.000 description 4
• 238000002741 site-directed mutagenesis Methods 0.000 description 4
• 238000006467 substitution reaction Methods 0.000 description 4
• 239000005720 sucrose Substances 0.000 description 4
• 230000009897 systematic effect Effects 0.000 description 4
• 230000005030 transcription termination Effects 0.000 description 4
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
• 108010078959 C-terminal processing peptidase Proteins 0.000 description 3
• 102000011591 Cleavage And Polyadenylation Specificity Factor Human genes 0.000 description 3
• 108010076130 Cleavage And Polyadenylation Specificity Factor Proteins 0.000 description 3
• 102000005221 Cleavage Stimulation Factor Human genes 0.000 description 3
• 108010081236 Cleavage Stimulation Factor Proteins 0.000 description 3
• 102000053602 DNA Human genes 0.000 description 3
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
• 241000588722 Escherichia Species 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• 238000012408 PCR amplification Methods 0.000 description 3
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 229920002472 Starch Polymers 0.000 description 3
• 238000009825 accumulation Methods 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
• 230000006399 behavior Effects 0.000 description 3
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 230000006652 catabolic pathway Effects 0.000 description 3
• 230000009194 climbing Effects 0.000 description 3
• 239000000470 constituent Substances 0.000 description 3
• 230000002596 correlated effect Effects 0.000 description 3
• 230000008878 coupling Effects 0.000 description 3
• 238000010168 coupling process Methods 0.000 description 3
• 238000005859 coupling reaction Methods 0.000 description 3
• 238000012517 data analytics Methods 0.000 description 3
• 239000005547 deoxyribonucleotide Substances 0.000 description 3
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 238000012224 gene deletion Methods 0.000 description 3
• 230000008826 genomic mutation Effects 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• 239000000543 intermediate Substances 0.000 description 3
• 238000012804 iterative process Methods 0.000 description 3
• 238000011031 large-scale manufacturing process Methods 0.000 description 3
• 238000012417 linear regression Methods 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 3
• 108091027963 non-coding RNA Proteins 0.000 description 3
• 102000042567 non-coding RNA Human genes 0.000 description 3
• 210000004940 nucleus Anatomy 0.000 description 3
• 235000015097 nutrients Nutrition 0.000 description 3
• 210000003463 organelle Anatomy 0.000 description 3
• 230000000243 photosynthetic effect Effects 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 238000009790 rate-determining step (RDS) Methods 0.000 description 3
• 239000002994 raw material Substances 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 230000011664 signaling Effects 0.000 description 3
• 238000011524 similarity measure Methods 0.000 description 3
• 239000008107 starch Substances 0.000 description 3
• 235000019698 starch Nutrition 0.000 description 3
• 239000013589 supplement Substances 0.000 description 3
• 238000012549 training Methods 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
• 102100036409 Activated CDC42 kinase 1 Human genes 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 241001137853 Crenarchaeota Species 0.000 description 2
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
• SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
• 239000003155 DNA primer Substances 0.000 description 2
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
• 241001137858 Euryarchaeota Species 0.000 description 2
• 208000031448 Genomic Instability Diseases 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 101000987310 Homo sapiens Serine/threonine-protein kinase PAK 2 Proteins 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
• 108060004795 Methyltransferase Proteins 0.000 description 2
• 238000006957 Michael reaction Methods 0.000 description 2
• FUSGACRLAFQQRL-UHFFFAOYSA-N N-Ethyl-N-nitrosourea Chemical compound CCN(N=O)C(N)=O FUSGACRLAFQQRL-UHFFFAOYSA-N 0.000 description 2
• VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 101710088675 Proline-rich peptide Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108010009736 Protein Hydrolysates Proteins 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 101710090029 Replication-associated protein A Proteins 0.000 description 2
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
• 108050008861 SH3 domains Proteins 0.000 description 2
• 102000000395 SH3 domains Human genes 0.000 description 2
• 241000831652 Salinivibrio sharmensis Species 0.000 description 2
• 241000607768 Shigella Species 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 108010023197 Streptokinase Proteins 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 108700009124 Transcription Initiation Site Proteins 0.000 description 2
• 108090000848 Ubiquitin Proteins 0.000 description 2
• 102400000757 Ubiquitin Human genes 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
• 108010017070 Zinc Finger Nucleases Proteins 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 150000001298 alcohols Chemical class 0.000 description 2
• 125000001931 aliphatic group Chemical group 0.000 description 2
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
• 210000004507 artificial chromosome Anatomy 0.000 description 2
• 230000003190 augmentative effect Effects 0.000 description 2
• 238000010923 batch production Methods 0.000 description 2
• GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 230000008827 biological function Effects 0.000 description 2
• 230000031018 biological processes and functions Effects 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 238000009395 breeding Methods 0.000 description 2
• 230000001488 breeding effect Effects 0.000 description 2
• 239000000337 buffer salt Substances 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 230000003915 cell function Effects 0.000 description 2
• 210000002421 cell wall Anatomy 0.000 description 2
• 241000902900 cellular organisms Species 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 229960004630 chlorambucil Drugs 0.000 description 2
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 2
• 230000008711 chromosomal rearrangement Effects 0.000 description 2
• 230000009918 complex formation Effects 0.000 description 2
• 238000010205 computational analysis Methods 0.000 description 2
• 238000005094 computer simulation Methods 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 230000001186 cumulative effect Effects 0.000 description 2
• 229960004397 cyclophosphamide Drugs 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 230000000368 destabilizing effect Effects 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 2
• 229940008406 diethyl sulfate Drugs 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 238000012407 engineering method Methods 0.000 description 2
• 230000000369 enteropathogenic effect Effects 0.000 description 2
• 230000000688 enterotoxigenic effect Effects 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 150000004665 fatty acids Chemical class 0.000 description 2
• 230000004907 flux Effects 0.000 description 2
• 230000037433 frameshift Effects 0.000 description 2
• 101150054895 ftsH gene Proteins 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 150000004676 glycans Chemical class 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 241001148029 halophilic archaeon Species 0.000 description 2
• IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 239000004310 lactic acid Substances 0.000 description 2
• 235000014655 lactic acid Nutrition 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 230000013011 mating Effects 0.000 description 2
• 229960001924 melphalan Drugs 0.000 description 2
• SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 2
• 229960001428 mercaptopurine Drugs 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
• MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 2
• 229960004857 mitomycin Drugs 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 238000010606 normalization Methods 0.000 description 2
• 230000008520 organization Effects 0.000 description 2
• 238000006116 polymerization reaction Methods 0.000 description 2
• 108010026466 polyproline Proteins 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 2
• 229960000624 procarbazine Drugs 0.000 description 2
• 210000001938 protoplast Anatomy 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 230000008707 rearrangement Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 238000009877 rendering Methods 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• 239000013605 shuttle vector Substances 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 125000006850 spacer group Chemical group 0.000 description 2
• 230000000087 stabilizing effect Effects 0.000 description 2
• 229960005202 streptokinase Drugs 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 230000002195 synergetic effect Effects 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 101150003509 tag gene Proteins 0.000 description 2
• 229960002898 threonine Drugs 0.000 description 2
• 230000005026 transcription initiation Effects 0.000 description 2
• IUCJMVBFZDHPDX-UHFFFAOYSA-N tretamine Chemical compound C1CN1C1=NC(N2CC2)=NC(N2CC2)=N1 IUCJMVBFZDHPDX-UHFFFAOYSA-N 0.000 description 2
• 229950001353 tretamine Drugs 0.000 description 2
• 230000001960 triggered effect Effects 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• 239000011782 vitamin Substances 0.000 description 2
• 235000013343 vitamin Nutrition 0.000 description 2
• 229930003231 vitamin Natural products 0.000 description 2
• 229940088594 vitamin Drugs 0.000 description 2
• UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
• 108020004465 16S ribosomal RNA Proteins 0.000 description 1
• PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
• MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
• 108020005345 3' Untranslated Regions Proteins 0.000 description 1
• FFKUHGONCHRHPE-UHFFFAOYSA-N 5-methyl-1h-pyrimidine-2,4-dione;7h-purin-6-amine Chemical compound CC1=CNC(=O)NC1=O.NC1=NC=NC2=C1NC=N2 FFKUHGONCHRHPE-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 241000186361 Actinobacteria <class> Species 0.000 description 1
• 241001439211 Almeida Species 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• 239000004254 Ammonium phosphate Substances 0.000 description 1
• 239000004382 Amylase Substances 0.000 description 1
• 108010065511 Amylases Proteins 0.000 description 1
• 102000013142 Amylases Human genes 0.000 description 1
• 101100002669 Arabidopsis thaliana ADT1 gene Proteins 0.000 description 1
• 101100002671 Arabidopsis thaliana ADT2 gene Proteins 0.000 description 1
• 101100002673 Arabidopsis thaliana ADT3 gene Proteins 0.000 description 1
• 101100216982 Arabidopsis thaliana ADT6 gene Proteins 0.000 description 1
• BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 101100228546 Bacillus subtilis (strain 168) folE2 gene Proteins 0.000 description 1
• 241000606125 Bacteroides Species 0.000 description 1
• 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 241000212384 Bifora Species 0.000 description 1
• 101800001415 Bri23 peptide Proteins 0.000 description 1
• 102400000107 C-terminal peptide Human genes 0.000 description 1
• 101800000655 C-terminal peptide Proteins 0.000 description 1
• 102100021786 CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase Human genes 0.000 description 1
• 108091033409 CRISPR Proteins 0.000 description 1
• 238000010354 CRISPR gene editing Methods 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
• 102000008122 Casein Kinase I Human genes 0.000 description 1
• 108010049812 Casein Kinase I Proteins 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 102000011068 Cdc42 Human genes 0.000 description 1
• 108050001278 Cdc42 Proteins 0.000 description 1
• 108010059892 Cellulase Proteins 0.000 description 1
• GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 241000191368 Chlorobi Species 0.000 description 1
• 241001142109 Chloroflexi Species 0.000 description 1
• 108091062157 Cis-regulatory element Proteins 0.000 description 1
• 241001112696 Clostridia Species 0.000 description 1
• 244000060011 Cocos nucifera Species 0.000 description 1
• 235000013162 Cocos nucifera Nutrition 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• 241000192700 Cyanobacteria Species 0.000 description 1
• 229930105110 Cyclosporin A Natural products 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 108010060248 DNA Ligase ATP Proteins 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 102100029995 DNA ligase 1 Human genes 0.000 description 1
• 238000000018 DNA microarray Methods 0.000 description 1
• 238000013382 DNA quantification Methods 0.000 description 1
• 238000012270 DNA recombination Methods 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 241000246067 Deinococcales Species 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 101100286286 Dictyostelium discoideum ipi gene Proteins 0.000 description 1
• IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 101100390711 Escherichia coli (strain K12) fhuA gene Proteins 0.000 description 1
• 101100432578 Escherichia coli (strain K12) ymgA gene Proteins 0.000 description 1
• 241001522878 Escherichia coli B Species 0.000 description 1
• 241000644323 Escherichia coli C Species 0.000 description 1
• 241001646716 Escherichia coli K-12 Species 0.000 description 1
• 241000617590 Escherichia coli K1 Species 0.000 description 1
• 241001590798 Escherichia coli NC101 Species 0.000 description 1
• 101100501444 Escherichia phage P1 17 gene Proteins 0.000 description 1
• 241000242711 Fasciola hepatica Species 0.000 description 1
• 241000230562 Flavobacteriia Species 0.000 description 1
• 229930091371 Fructose Natural products 0.000 description 1
• 239000005715 Fructose Substances 0.000 description 1
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
• 230000005526 G1 to G0 transition Effects 0.000 description 1
• 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
• 108091006109 GTPases Proteins 0.000 description 1
• 206010017577 Gait disturbance Diseases 0.000 description 1
• 102100039555 Galectin-7 Human genes 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 229930191978 Gibberellin Natural products 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 108010070675 Glutathione transferase Proteins 0.000 description 1
• 102000005720 Glutathione transferase Human genes 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
• 101100277701 Halobacterium salinarum gdhX gene Proteins 0.000 description 1
• 229920002488 Hemicellulose Polymers 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000919320 Homo sapiens Adapter molecule crk Proteins 0.000 description 1
• 101000752722 Homo sapiens Apoptosis-stimulating of p53 protein 1 Proteins 0.000 description 1
• 101000616698 Homo sapiens CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase Proteins 0.000 description 1
• 101000902096 Homo sapiens Disks large homolog 4 Proteins 0.000 description 1
• 101000608772 Homo sapiens Galectin-7 Proteins 0.000 description 1
• 101001120056 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit alpha Proteins 0.000 description 1
• 101001120097 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit beta Proteins 0.000 description 1
• 101001116549 Homo sapiens Protein CBFA2T2 Proteins 0.000 description 1
• 101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 description 1
• 101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 108010059881 Lactase Proteins 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 241000186660 Lactobacillus Species 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
• 108090001060 Lipase Proteins 0.000 description 1
• 102000004882 Lipase Human genes 0.000 description 1
• 239000004367 Lipase Substances 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 241000192041 Micrococcus Species 0.000 description 1
• 241001430197 Mollicutes Species 0.000 description 1
• PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101100497327 Mus musculus Crk gene Proteins 0.000 description 1
• 102000010645 MutS Proteins Human genes 0.000 description 1
• 108010038272 MutS Proteins Proteins 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
• 102100023031 Neural Wiskott-Aldrich syndrome protein Human genes 0.000 description 1
• 101710134234 Neural Wiskott-Aldrich syndrome protein Proteins 0.000 description 1
• 108020004485 Nonsense Codon Proteins 0.000 description 1
• 108091005461 Nucleic proteins Chemical group 0.000 description 1
• 101700056750 PAK1 Proteins 0.000 description 1
• 108091007960 PI3Ks Proteins 0.000 description 1
• 235000021314 Palmitic acid Nutrition 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 108010013639 Peptidoglycan Proteins 0.000 description 1
• 239000001888 Peptone Substances 0.000 description 1
• 108010080698 Peptones Proteins 0.000 description 1
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 101100392454 Picrophilus torridus (strain ATCC 700027 / DSM 9790 / JCM 10055 / NBRC 100828) gdh2 gene Proteins 0.000 description 1
• 241000589952 Planctomyces Species 0.000 description 1
• 108700001094 Plant Genes Proteins 0.000 description 1
• 108010059820 Polygalacturonase Proteins 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 101710118538 Protease Proteins 0.000 description 1
• 241000192142 Proteobacteria Species 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 238000003559 RNA-seq method Methods 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 101100296194 Rattus norvegicus Pak1 gene Proteins 0.000 description 1
• 108700005075 Regulator Genes Proteins 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 102000002278 Ribosomal Proteins Human genes 0.000 description 1
• 108010000605 Ribosomal Proteins Proteins 0.000 description 1
• 101100116769 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) gdhA-2 gene Proteins 0.000 description 1
• 240000000111 Saccharum officinarum Species 0.000 description 1
• 235000007201 Saccharum officinarum Nutrition 0.000 description 1
• 101710204410 Scaffold protein Proteins 0.000 description 1
• 101100463170 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pdt1 gene Proteins 0.000 description 1
• 101100465937 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pst3 gene Proteins 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 102100027910 Serine/threonine-protein kinase PAK 1 Human genes 0.000 description 1
• 102100027939 Serine/threonine-protein kinase PAK 2 Human genes 0.000 description 1
• 102100027940 Serine/threonine-protein kinase PAK 4 Human genes 0.000 description 1
• 101710148155 Serine/threonine-protein kinase PAK 4 Proteins 0.000 description 1
• 108010017898 Shiga Toxins Proteins 0.000 description 1
• 241000607762 Shigella flexneri Species 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 241000589970 Spirochaetales Species 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 1
• 208000003028 Stuttering Diseases 0.000 description 1
• 235000021536 Sugar beet Nutrition 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 235000019486 Sunflower oil Nutrition 0.000 description 1
• 108090000916 Syntrophin Proteins 0.000 description 1
• 102000004402 Syntrophin Human genes 0.000 description 1
• 241000204315 Thermosipho <sea snail> Species 0.000 description 1
• 241000204652 Thermotoga Species 0.000 description 1
• JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 101710120037 Toxin CcdB Proteins 0.000 description 1
• 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 101150071882 US17 gene Proteins 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 108700040099 Xylose isomerases Proteins 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 238000003314 affinity selection Methods 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 239000001099 ammonium carbonate Substances 0.000 description 1
• 235000012501 ammonium carbonate Nutrition 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
• 235000019289 ammonium phosphates Nutrition 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 235000019418 amylase Nutrition 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 239000002518 antifoaming agent Substances 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
• 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 239000013602 bacteriophage vector Substances 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 238000012365 batch cultivation Methods 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 229940041514 candida albicans extract Drugs 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 150000001722 carbon compounds Chemical class 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 230000001364 causal effect Effects 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000033077 cellular process Effects 0.000 description 1
• 229940106157 cellulase Drugs 0.000 description 1
• 235000013351 cheese Nutrition 0.000 description 1
• 239000002962 chemical mutagen Substances 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 235000015165 citric acid Nutrition 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 101150096566 clpX gene Proteins 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000009850 completed effect Effects 0.000 description 1
• 238000000205 computational method Methods 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 238000012364 cultivation method Methods 0.000 description 1
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 238000013500 data storage Methods 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
• 230000003467 diminishing effect Effects 0.000 description 1
• 210000001840 diploid cell Anatomy 0.000 description 1
• ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 230000001516 effect on protein Effects 0.000 description 1
• 230000001094 effect on targets Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 239000003256 environmental substance Substances 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 108010093305 exopolygalacturonase Proteins 0.000 description 1
• 230000003631 expected effect Effects 0.000 description 1
• 239000002360 explosive Substances 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 235000019197 fats Nutrition 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 235000013312 flour Nutrition 0.000 description 1
• 101150014423 fni gene Proteins 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 231100000221 frame shift mutation induction Toxicity 0.000 description 1
• 230000000855 fungicidal effect Effects 0.000 description 1
• 239000000417 fungicide Substances 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000012268 genome sequencing Methods 0.000 description 1
• IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
• 239000003448 gibberellin Substances 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
• DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
• 229960002867 griseofulvin Drugs 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 108010002430 hemicellulase Proteins 0.000 description 1
• 229940059442 hemicellulase Drugs 0.000 description 1
• SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 description 1
• 229940124736 hepatitis-B vaccine Drugs 0.000 description 1
• 238000012165 high-throughput sequencing Methods 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 230000001861 immunosuppressant effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000009655 industrial fermentation Methods 0.000 description 1
• 239000003317 industrial substance Substances 0.000 description 1
• 150000002484 inorganic compounds Chemical class 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000002917 insecticide Substances 0.000 description 1
• 239000012212 insulator Substances 0.000 description 1
• 230000003426 interchromosomal effect Effects 0.000 description 1
• 230000010039 intracellular degradation Effects 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 229910000358 iron sulfate Inorganic materials 0.000 description 1
• BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 150000002576 ketones Chemical class 0.000 description 1
• 229940116108 lactase Drugs 0.000 description 1
• 229940039696 lactobacillus Drugs 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 229920005610 lignin Polymers 0.000 description 1
• 235000020778 linoleic acid Nutrition 0.000 description 1
• OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
• 235000019421 lipase Nutrition 0.000 description 1
• 229940040461 lipase Drugs 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
• 229960004844 lovastatin Drugs 0.000 description 1
• QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 235000013372 meat Nutrition 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 210000005060 membrane bound organelle Anatomy 0.000 description 1
• 230000008986 metabolic interaction Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• 230000002906 microbiologic effect Effects 0.000 description 1
• 238000009629 microbiological culture Methods 0.000 description 1
• 235000013379 molasses Nutrition 0.000 description 1
• 238000003032 molecular docking Methods 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• 150000002772 monosaccharides Chemical class 0.000 description 1
• WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
• 210000000633 nuclear envelope Anatomy 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 235000014593 oils and fats Nutrition 0.000 description 1
• 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 150000002894 organic compounds Chemical class 0.000 description 1
• 125000001477 organic nitrogen group Chemical group 0.000 description 1
• 101150071010 osmE gene Proteins 0.000 description 1
• 229940055726 pantothenic acid Drugs 0.000 description 1
• 235000019161 pantothenic acid Nutrition 0.000 description 1
• 239000011713 pantothenic acid Substances 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 235000019319 peptone Nutrition 0.000 description 1
• 229940066779 peptones Drugs 0.000 description 1
• 101150023849 pheA gene Proteins 0.000 description 1
• 230000009120 phenotypic response Effects 0.000 description 1
• PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 238000000596 photon cross correlation spectroscopy Methods 0.000 description 1
• 230000029553 photosynthesis Effects 0.000 description 1
• 238000010672 photosynthesis Methods 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 239000003375 plant hormone Substances 0.000 description 1
• 238000013492 plasmid preparation Methods 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920002857 polybutadiene Polymers 0.000 description 1
• 229920001522 polyglycol ester Polymers 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 229930010796 primary metabolite Natural products 0.000 description 1
• 239000002987 primer (paints) Substances 0.000 description 1
• 238000012913 prioritisation Methods 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000006916 protein interaction Effects 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• 101150108487 pst2 gene Proteins 0.000 description 1
• 239000013014 purified material Substances 0.000 description 1
• 239000012264 purified product Substances 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 210000003660 reticulum Anatomy 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 101150034869 rpo5 gene Proteins 0.000 description 1
• 101150106872 rpoH gene Proteins 0.000 description 1
• 101150025220 sacB gene Proteins 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 150000004671 saturated fatty acids Chemical class 0.000 description 1
• 235000003441 saturated fatty acids Nutrition 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 230000009291 secondary effect Effects 0.000 description 1
• 229930000044 secondary metabolite Natural products 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000004904 shortening Methods 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 108060007624 small GTPase Proteins 0.000 description 1
• 102000030938 small GTPase Human genes 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 230000007928 solubilization Effects 0.000 description 1
• 238000005063 solubilization Methods 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 230000003595 spectral effect Effects 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 238000001370 static light scattering Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 239000002600 sunflower oil Substances 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 230000009293 tertiary effect Effects 0.000 description 1
• 235000019157 thiamine Nutrition 0.000 description 1
• KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
• 229960003495 thiamine Drugs 0.000 description 1
• 239000011721 thiamine Substances 0.000 description 1
• 230000005029 transcription elongation Effects 0.000 description 1
• 238000011426 transformation method Methods 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
• 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
• 229940045145 uridine Drugs 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1
• 238000012418 validation experiment Methods 0.000 description 1
• 239000000052 vinegar Substances 0.000 description 1
• 235000021419 vinegar Nutrition 0.000 description 1
• 101150103853 yciA gene Proteins 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1
• 239000012138 yeast extract Substances 0.000 description 1
• 235000013618 yogurt Nutrition 0.000 description 1